Photodynamic black phosphorus nanosheets functionalized with polymyxin B for targeted ablation of drug-resistant mixed-species biofilms
J Yu, C Li, W Zhang, Y Li, W Miao, H Huang - Journal of Controlled Release, 2024 - Elsevier
Biofilms, particularly those formed by multiple bacterial species, pose significant economic
and environmental challenges, especially in the context of medical implants. Addressing the …
and environmental challenges, especially in the context of medical implants. Addressing the …
Antimicrobial Peptides and Their Assemblies
AM Carmona-Ribeiro - Future Pharmacology, 2023 - mdpi.com
Antibiotic resistance requires alternatives to fight multi-drug resistant strains. Antimicrobial
peptides (AMPs) act by disrupting or solubilizing microbial cell walls or membranes in …
peptides (AMPs) act by disrupting or solubilizing microbial cell walls or membranes in …
Hyaluronic Acid-Modified Micelles of Azithromycin and Quercetin Against Infections Caused by Methicillin-Resistant Staphylococcus Aureus
Z Zhang, M Chen, J Wang, M Liu, R Guo… - International Journal …, 2024 - Taylor & Francis
Introduction Resistance of intracellular pathogens is a challenge in microbial therapy.
Methicillin-resistant Staphylococcus aureus (MRSA), which is able to persist inside the cells …
Methicillin-resistant Staphylococcus aureus (MRSA), which is able to persist inside the cells …
Plasmonic nano-bowls for monitoring intra-membrane changes in liposomes, and DNA-based nanocarriers in suspension
Programmable nanoscale carriers, such as liposomes and DNA, are readily being explored
for personalized medicine or disease prediction and diagnostics. The characterization of …
for personalized medicine or disease prediction and diagnostics. The characterization of …
Antimicrobial peptide-modified pH-sensitive micelles against pneumonia caused by methicillin-resistant Staphylococcus aureus
Y Wang, B Xu, L Jiang, J Yan, Z Liu, S Li, D Liu… - Journal of Drug Delivery …, 2024 - Elsevier
Bacterial infections in the lungs can cause severe illness and pose a heavy economic
burden. Antibiotics are the first clinical choice to combat bacterial infections, but most of them …
burden. Antibiotics are the first clinical choice to combat bacterial infections, but most of them …
Nanoantibiotics driven approaches as an advanced therapy for bacterial infections and chemotherapeutic resistance
In recent times, the rise of antimicrobial resistance presents a grave risk to human well-
being, encompassing the potential for acute illness and life-threatening consequences …
being, encompassing the potential for acute illness and life-threatening consequences …